{"id":"https://openalex.org/W7224938334","doi":"https://doi.org/10.3390/pharmacy14080161","title":"Assessing the Knowledge and Awareness of Community Pharmacists Regarding Warfarin Therapy in Jeddah and Taif, Saudi Arabia","display_name":"Assessing the Knowledge and Awareness of Community Pharmacists Regarding Warfarin Therapy in Jeddah and Taif, Saudi Arabia","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7224938334","doi":"https://doi.org/10.3390/pharmacy14080161"},"language":"en","primary_location":{"id":"doi:10.3390/pharmacy14080161","doi":"https://doi.org/10.3390/pharmacy14080161","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmacy14080161","pdf_url":null,"source":{"id":"https://openalex.org/S4210228566","display_name":"Pharmacy","issn_l":"2226-4787","issn":["2226-4787"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/pharmacy14080161","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028541412","display_name":"Ahmed Basilim","orcid":"https://orcid.org/0000-0003-0505-1360","observed_orcids":["https://orcid.org/0000-0003-0505-1360"]},"institutions":[{"id":"https://openalex.org/I185163786","display_name":"King Abdulaziz University","ror":"https://ror.org/02ma4wv74","country_code":"SA","type":"education","lineage":["https://openalex.org/I185163786"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Ahmed Basilim","raw_affiliation_strings":["Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0003-0505-1360","affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia","institution_ids":["https://openalex.org/I185163786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160163908","display_name":"Futoon Althobaiti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185163786","display_name":"King Abdulaziz University","ror":"https://ror.org/02ma4wv74","country_code":"SA","type":"education","lineage":["https://openalex.org/I185163786"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Futoon Althobaiti","raw_affiliation_strings":["Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia","institution_ids":["https://openalex.org/I185163786"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160205084","display_name":"Layan Alghamdi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185163786","display_name":"King Abdulaziz University","ror":"https://ror.org/02ma4wv74","country_code":"SA","type":"education","lineage":["https://openalex.org/I185163786"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Layan Alghamdi","raw_affiliation_strings":["Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia","institution_ids":["https://openalex.org/I185163786"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160179981","display_name":"Salha Alsaigh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185163786","display_name":"King Abdulaziz University","ror":"https://ror.org/02ma4wv74","country_code":"SA","type":"education","lineage":["https://openalex.org/I185163786"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Salha Alsaigh","raw_affiliation_strings":["Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia","institution_ids":["https://openalex.org/I185163786"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5028541412"],"corresponding_institution_ids":["https://openalex.org/I185163786"],"apc_list":{"value":1800,"currency":"CHF","value_usd":2172},"apc_paid":{"value":1800,"currency":"CHF","value_usd":2172},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.89212426,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"8","first_page":"161","last_page":"161"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9800000190734863},{"id":"https://openalex.org/keywords/community-pharmacists","display_name":"community pharmacists","score":0.9710000157356262},{"id":"https://openalex.org/keywords/pharmacist-knowledge","display_name":"pharmacist knowledge","score":0.8320000171661377},{"id":"https://openalex.org/keywords/anticoagulation-safety","display_name":"anticoagulant safety","score":0.6809999942779541},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.9739999771118164},{"id":"https://openalex.org/keywords/patient-counseling","display_name":"patient counseling","score":0.9599999785423279},{"id":"https://openalex.org/keywords/anticoagulation-monitoring","display_name":"anticoagulation monitoring","score":0.8330000042915344},{"id":"https://openalex.org/keywords/continuing-professional-development","display_name":"continuing professional development","score":0.8740000128746033},{"id":"https://openalex.org/keywords/pharmacist-certification","display_name":"pharmacist certification","score":0.45399999618530273},{"id":"https://openalex.org/keywords/saudi-arabia","display_name":"Saudi Arabia","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8695999979972839},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.6435999870300293},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.5620999932289124},{"id":"https://openalex.org/C2992750412","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Oral anticoagulant","level":4,"score":0.5120999813079834},{"id":"https://openalex.org/C39896193","wikidata":"https://www.wikidata.org/wiki/Q380344","display_name":"Descriptive statistics","level":2,"score":0.44690001010894775},{"id":"https://openalex.org/C94124525","wikidata":"https://www.wikidata.org/wiki/Q912550","display_name":"Categorization","level":2,"score":0.3767000138759613},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.2962999939918518},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2777999937534332},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.27309998869895935},{"id":"https://openalex.org/C142052008","wikidata":"https://www.wikidata.org/wiki/Q954027","display_name":"Cross-sectional study","level":2,"score":0.2718999981880188},{"id":"https://openalex.org/C137403100","wikidata":"https://www.wikidata.org/wiki/Q41710","display_name":"Ethnic group","level":2,"score":0.26249998807907104},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2599000036716461},{"id":"https://openalex.org/C2993316766","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant therapy","level":2,"score":0.25870001316070557},{"id":"https://openalex.org/C2779861157","wikidata":"https://www.wikidata.org/wiki/Q5154967","display_name":"Community hospital","level":2,"score":0.2515000104904175}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3390/pharmacy14080161","doi":"https://doi.org/10.3390/pharmacy14080161","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmacy14080161","pdf_url":null,"source":{"id":"https://openalex.org/S4210228566","display_name":"Pharmacy","issn_l":"2226-4787","issn":["2226-4787"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3390/pharmacy14080161","doi":"https://doi.org/10.3390/pharmacy14080161","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmacy14080161","pdf_url":null,"source":{"id":"https://openalex.org/S4210228566","display_name":"Pharmacy","issn_l":"2226-4787","issn":["2226-4787"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1784113710","https://openalex.org/W2068476516","https://openalex.org/W2124667840","https://openalex.org/W2131285802","https://openalex.org/W2140878413","https://openalex.org/W2147800728","https://openalex.org/W2156834133","https://openalex.org/W2182894602","https://openalex.org/W2282258694","https://openalex.org/W2768663712","https://openalex.org/W2773464982","https://openalex.org/W2799729742","https://openalex.org/W2980659835","https://openalex.org/W3028727122","https://openalex.org/W3033435090","https://openalex.org/W3044324632","https://openalex.org/W3090209681","https://openalex.org/W3136441191","https://openalex.org/W4308370376","https://openalex.org/W4379647698","https://openalex.org/W4389166035","https://openalex.org/W4389782616","https://openalex.org/W4389994749","https://openalex.org/W4400228845","https://openalex.org/W4400639860","https://openalex.org/W4410946317","https://openalex.org/W4414858862","https://openalex.org/W7162283486"],"related_works":["https://openalex.org/W4311133610","https://openalex.org/W7167895249","https://openalex.org/W4220656181","https://openalex.org/W2140901947","https://openalex.org/W1536689101","https://openalex.org/W2596693251","https://openalex.org/W2347088818","https://openalex.org/W7215767913","https://openalex.org/W4200099850","https://openalex.org/W4385727728"],"abstract_inverted_index":{"Background/Objectives:":[0],"Although":[1],"warfarin":[2],"remains":[3],"an":[4,25,35],"important":[5,36],"oral":[6],"anticoagulant":[7,29],"for":[8,113,130,171,174,178],"selected":[9],"indications,":[10],"careful":[11],"monitoring":[12,30],"is":[13,294],"required":[14],"due":[15],"to":[16,67,102,157],"its":[17],"narrow":[18],"therapeutic":[19],"index":[20],"and":[21,49,56,74,80,99,182,203,288,296,303],"numerous":[22],"interactions.":[23],"As":[24],"integral":[26],"part":[27],"of":[28,51,78,82,126,187,196],"systems":[31],"globally,":[32],"pharmacists":[33,53,71],"play":[34],"role":[37],"in":[38,54,72,285],"preventing":[39],"warfarin-associated":[40],"complications.":[41],"The":[42,84],"current":[43],"study":[44],"assessed":[45],"the":[46,119,162,192,214,217,263],"warfarin-related":[47],"knowledge":[48,88,100],"awareness":[50,108],"community":[52,70],"Jeddah":[55,73],"Taif,":[57],"Saudi":[58],"Arabia.":[59],"Methods:":[60],"This":[61],"cross-sectional":[62],"survey":[63],"used":[64,129,136],"convenience":[65],"sampling":[66],"recruit":[68],"380":[69],"Taif":[75],"between":[76],"October":[77],"2024":[79],"March":[81],"2025.":[83],"questionnaire":[85],"included":[86],"19":[87],"items":[89],"covering":[90],"warfarin\u2019s":[91],"safety":[92],"(eight":[93],"items),":[94,98],"drug":[95,175],"interactions":[96],"(six":[97],"related":[101],"patient":[103,179,304],"counseling":[104,180,301],"(five":[105],"items).":[106],"Percentage":[107],"scores":[109],"(PASs)":[110],"were":[111,169,206,283],"calculated":[112],"each":[114],"domain,":[115],"as":[116,118,144],"well":[117],"overall":[120,163,223,246],"PAS.":[121,164],"A":[122,185],"predefined":[123,193,264],"PAS":[124,167,194,211,224,247,266],"threshold":[125,195],"\u226560%":[127],"was":[128,155,241],"descriptive":[131,265],"categorization":[132],"only.":[133],"Unadjusted":[134],"comparisons":[135],"independent-samples":[137],"t-tests,":[138],"with":[139,151,161,210,244],"Mann\u2013Whitney":[140],"U":[141],"tests":[142],"performed":[143],"sensitivity":[145],"analyses.":[146],"Multivariable":[147],"linear":[148],"regression":[149],"analysis":[150],"robust":[152],"standard":[153],"errors":[154],"conducted":[156],"examine":[158,300],"adjusted":[159],"associations":[160],"Results:":[165],"Mean":[166],"values":[168],"65.39%":[170],"safety,":[172,286],"61.18%":[173],"interactions,":[176,287],"74.26%":[177],"knowledge,":[181],"66.40%":[183],"overall.":[184],"total":[186],"258":[188],"participants":[189,261],"(67.9%)":[190],"exceeded":[191],"\u226560%.":[197],"Gender,":[198],"age,":[199],"experience,":[200],"board":[201],"certification,":[202],"anticoagulation":[204],"training":[205],"not":[207,276],"significantly":[208],"associated":[209,243],"values.":[212],"In":[213],"multivariable":[215],"analysis,":[216],"combined":[218],"non-BPharm":[219],"group":[220],"had":[221],"higher":[222,245],"than":[225],"BPharm":[226],"holders":[227],"(adjusted":[228,248],"difference:":[229,249],"5.99":[230],"percentage":[231,251],"points;":[232,252],"95%":[233,253],"CI:":[234,254],"2.54\u20139.44;":[235],"p":[236,256],"<":[237],"0.001).":[238],"Non-Saudi":[239],"nationality":[240],"also":[242],"4.27":[250],"0.05\u20138.48;":[255],"=":[257],"0.047).":[258],"Conclusions:":[259],"Most":[260],"met":[262],"threshold,":[267],"although":[268],"it":[269],"should":[270,299],"be":[271],"noted":[272],"that":[273],"this":[274],"does":[275],"establish":[277],"clinically":[278],"adequate":[279],"knowledge.":[280],"Nevertheless,":[281],"gaps":[282],"identified":[284],"counseling.":[289],"Targeted":[290],"continuing":[291],"professional":[292],"education":[293],"warranted,":[295],"future":[297],"studies":[298],"practices":[302],"outcomes.":[305]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-31T00:00:00"}